JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$2.63B |
| 2 |
JPMorgan BetaBuilders Japan ETF
BBJP
|
+$1.83B |
| 3 |
JPMorgan BetaBuilders International Equity ETF
BBIN
|
+$1.55B |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$1B |
| 5 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$884M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI EAFE ETF
IEFA
|
+$1.8B |
| 2 |
iShares MSCI EAFE ETF
EFA
|
+$1.77B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$884M |
| 4 |
iShares Core US Aggregate Bond ETF
AGG
|
+$880M |
| 5 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$834M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 26.09% |
| 2 | Technology | 16.19% |
| 3 | Financials | 10.76% |
| 4 | Healthcare | 10.54% |
| 5 | Consumer Discretionary | 10.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2326
Vishay Precision Group
VPG
$1.04B
| $5.17M | ﹤0.01% |
210,475
+156,205
| +288% | +$3.51M |
2015 Q4
18 quarters
|
|
2327
Boston Beer
SAM
$1.74B
| $5.17M | ﹤0.01% |
9,631
-17,740
| -65% | -$8.59M |
2014 Q3
23 quarters
|
|
2328
Newmark Group
NMRK
$2.32B
| $5.16M | ﹤0.01% |
1,060,798
-106,751
| -9% | -$449K |
2017 Q4
10 quarters
|
|
2329
PUT
Vale
VALE
$60.5B
| $5.16M | ﹤0.01% |
500,000
-500,000
| -50% | -$4.58M |
2014 Q4
22 quarters
|
|
2330
Karyopharm Therapeutics
KPTI
$15.1M
| $5.14M | ﹤0.01% |
18,079
+897
| +5% | +$265K |
2013 Q4
26 quarters
|
|
2331
Glaukos
GKOS
$9.61B
| $5.13M | ﹤0.01% |
133,421
+31,735
| +31% | +$1.18M |
2016 Q1
17 quarters
|
|
2332
Standard BioTools
LAB
$290M
| $5.12M | ﹤0.01% |
1,275,958
+254,868
| +25% | +$888K |
2016 Q4
14 quarters
|
|
2333
Ovintiv
OVV
$17B
| $5.11M | ﹤0.01% |
535,486
-220,172
| -29% | -$1.54M |
2013 Q2
28 quarters
|
|
2334
PennyMac Financial
PFSI
$3.26B
| $5.11M | ﹤0.01% |
122,225
-155,965
| -56% | -$4.94M |
2014 Q3
23 quarters
|
|
2335
Myriad Genetics
MYGN
$415M
| $5.1M | ﹤0.01% |
449,907
+123,305
| +38% | +$1.75M |
2013 Q2
28 quarters
|
|
|
BCPC
2336
Balchem Corp
BCPC
$5.29B
| $5.1M | ﹤0.01% |
53,741
+3,758
| +8% | +$351K |
2015 Q2
20 quarters
|
|
2337
Community Health Systems
CYH
$398M
| $5.1M | ﹤0.01% |
1,692,936
-1,073,152
| -39% | -$3.45M |
2013 Q2
28 quarters
|
|
|
PETQ
2338
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
| $5.08M | ﹤0.01% |
145,824
+85,280
| +141% | +$2.39M |
2017 Q4
10 quarters
|
|
|
TWOU
2339
DELISTED
2U Inc
TWOU
| $5.08M | ﹤0.01% |
4,458
-5,013
| -53% | -$4.48M |
2014 Q2
24 quarters
|
|
2340
CALL
State Street Communication Services Select Sector SPDR ETF
XLC
$23.2B
| $5.07M | ﹤0.01% |
+93,900
| New | +$4.82M |
2020 Q2
0 quarters
|
|
2341
Gogo Inc
GOGO
$299M
| $5.07M | ﹤0.01% |
1,604,837
+1,262,914
| +369% | +$2.72M |
2016 Q3
15 quarters
|
|
2342
Rollins
ROL
$14.6B
| $5.07M | ﹤0.01% |
179,246
+5,225
| +3% | +$140K |
2015 Q4
18 quarters
|
|
2343
PUT
Dine Brands
DIN
$381M
| $5.05M | ﹤0.01% |
+120,000
| New | +$4.84M |
2020 Q2
0 quarters
|
|
2344
Invesco Variable Rate Preferred ETF
VRP
$3B
| $5.04M | ﹤0.01% |
215,332
-50,927
| -19% | -$1.18M |
2016 Q2
16 quarters
|
|
2345
Insmed
INSM
$23.1B
| $5.04M | ﹤0.01% |
182,977
-12,234
| -6% | -$290K |
2013 Q2
28 quarters
|
|
2346
PUT
PepsiCo
PEP
$173B
| $5.04M | ﹤0.01% |
38,100
-28,500
| -43% | -$3.76M |
2018 Q2
8 quarters
|
|
2347
Yeti Holdings
YETI
$2.96B
| $5.04M | ﹤0.01% |
117,919
-567,160
| -83% | -$17M |
2018 Q4
6 quarters
|
|
2348
Conduent
CNDT
$257M
| $5.02M | ﹤0.01% |
2,101,914
+1,758,564
| +512% | +$4.09M |
2017 Q1
13 quarters
|
|
|
DHC
2349
Diversified Healthcare Trust
DHC
$1.85B
| $5.02M | ﹤0.01% |
1,133,885
-1,394,700
| -55% | -$4.93M |
2020 Q1
1 quarter
|
|
2350
Elbit Systems
ESLT
$32.5B
| $5.02M | ﹤0.01% |
36,599
-9,801
| -21% | -$1.32M |
2013 Q2
28 quarters
|
|
Similar funds
JP Morgan Chase's Q2 2020 Portfolio in Review
As of Q2 2020, JP Morgan Chase held 5,976 positions worth $518B, up 22% from $426B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q2 2020 filing shows 640 new, 2,055 increased, 2,340 reduced and 398 closed positions. Its largest new stake was JPMorgan BetaBuilders International Equity ETF: 35,626,738 shares worth $1.64B. The largest sale was iShares Core MSCI EAFE ETF, an estimated $1.8B.
By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, down from 28% a quarter earlier, followed by Technology and Financials.
- JP Morgan Chase's largest Q2 2020 buy was JPMorgan BetaBuilders International Equity ETF: 35,626,738 shares worth $1.64B.
- JP Morgan Chase added most to JPMorgan BetaBuilders Europe ETF in Q2 2020, an estimated $2.63B increase.
- JP Morgan Chase's biggest Q2 2020 reduction was iShares Core MSCI EAFE ETF, cutting an estimated $1.8B.
- JP Morgan Chase fully exited Allergan plc in Q2 2020, selling an estimated $656M.
- JP Morgan Chase's ten largest holdings make up 17% of its $518B portfolio in Q2 2020.
- JP Morgan Chase opened 640 new positions and closed 398 in Q2 2020.
- JP Morgan Chase's portfolio value rose 22% quarter-over-quarter to $518B.
Based on JP Morgan Chase's 13F filing for Q2 2020, filed 11 Aug 2020.